## ASML: ASML Holding N.V. - New York Re - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1026.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Geneos Wealth Management Inc. Increases Stock Holdings in ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251215T090904 | Bullish | Relevance: 100%
- Geneos Wealth Management Inc. significantly increased its stake in ASML Holding N.V. by 242.6% in the second quarter, acquiring an additional 4,798 shares to own a total of 6,776 shares valued at approximately $5.43 million. ASML reported strong quarterly earnings, beating analyst estimates, although revenue slightly missed expectations. The company also recently raised its quarterly dividend to $1.857 per share and has a "Moderate Buy" consensus rating from analysts with an average price target of $1,171.83.

**2. Marex Group plc Purchases Shares of 2,417 ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251214T120924 | Bullish | Relevance: 100%
- Marex Group plc initiated a new position in ASML Holding N.V. (NASDAQ:ASML) during the second quarter, acquiring 2,417 shares valued at approximately $1.94 million. ASML has a "Moderate Buy" consensus rating from analysts with a target price of $1,171.83, and its financial performance shows solid earnings and revenue, alongside a recently increased quarterly dividend. The company, a key player in semiconductor equipment, has seen significant institutional interest and positive analyst upgrades.

**3. 5,389 Shares in ASML Holding N.V. $ASML Acquired by B. Riley Wealth Advisors Inc.**
- Source: MarketBeat | 20251214T090925 | Somewhat-Bullish | Relevance: 100%
- B. Riley Wealth Advisors Inc. has acquired 5,389 shares of ASML Holding N.V., valued at approximately $4.32 million, as part of increased institutional investment in the semiconductor company. ASML notably exceeded EPS forecasts but slightly missed revenue expectations, and the company has raised its quarterly dividend to $1.857, translating to an annualized yield of about 0.7%. Analyst sentiment towards ASML remains largely positive, with an average "Moderate Buy" rating and a price target of $1,171.83.

**4. ASML Holding N.V. $ASML Stock Holdings Trimmed by Light Street Capital Management LLC**
- Source: MarketBeat | 20251213T140911 | Somewhat-Bullish | Relevance: 100%
- Light Street Capital Management LLC reduced its stake in ASML Holding N.V. (NASDAQ:ASML) by 21.4% in the second quarter, now holding 5,511 shares valued at $4.42 million. Despite the trim, ASML remains a significant position for the firm and carries a "Moderate Buy" consensus rating from analysts, with various other institutional investors increasing their holdings. The company recently beat EPS estimates, slightly missed revenue, and increased its quarterly dividend.

**5. Lone Pine Capital LLC Sells 15,565 Shares of ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251213T130911 | Bullish | Relevance: 100%
- Lone Pine Capital LLC reduced its stake in ASML Holding N.V. by 2.7% in Q2, selling 15,565 shares but still holding over 566,000 shares valued at approximately $454.3 million. Despite this sale, ASML remains a significant holding for Lone Pine, while other institutional investors like T. Rowe Price and Fisher Asset Management increased their positions. Analysts maintain a "Moderate Buy" rating for ASML, with the company reporting strong EPS and revenue.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Premium valuation (P/E 42x, PEG 2.1x) vulnerable to multiple compression.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 42.0x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $422.2B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 42.0 |
| Current P/E | 44.0 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.4% to -0.3% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.0%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.31% (CS: 24) | Neutral |
| RSI_14 | 54.3 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 1.320x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1087.82
- **Stop Loss:** $1026.12 (5.7% risk)
- **Target:** $1149.52 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 16
- **Position Value:** $17,405.12
- **Portfolio %:** 17.41%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*